Science ❯Medical Research ❯Clinical Trials

Oncology

mRNA Technology Survival Rates AI Technology Glioblastoma Research Precision Medicine

Aberdeen Launches World-First Trial of Low-Field MRI Scanner for Glioblastoma

By varying magnetic intensity during low-field scans, the researchers aim to pinpoint true tumour progression without contrast dye

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

AI test identifies which prostate cancer patients could halve their death risk with abiraterone

Immunotherapy Drug Significantly Improves Survival Rates in Bladder Cancer

Experimental mRNA Vaccine Shows Promise in Early Cancer Trials